Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diagnostic HYBRIDS
Diagnostic HYBRIDS and Case Western Reserve University Announce Licensing Agreement for the Development of an HIV Tropism and Drug Resistance Platform
February 18th, 2009
Diagnostic HYBRIDS and Case Western Reserve University have signed an exclusive worldwide licensing agreement granting Diagnostic HYBRIDS rights to a novel yeast-based virus cloning technology invented by noted Human Immunodeficiency Virus (HIV) researcher Eric Arts, Ph.D., Associate Professor of Medicine in the Division of Infectious Diseases, Department of Medicine at Case Western Reserve School of Medicine. The technology provides a platform of diagnostic tests used by physicians and researchers to monitor the success of anti-HIV treatment by determining drug resistance and disease “strength” of the virus. The technology can also be used for academic research to better understand this...
Source: Vaccine Weekly (2009-02-18)
|
